Internal Medicine · Fajardo, PR
NPI
1811076813
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Calle Union Num 10 Este, Fajardo Medical Plaza 102
Fajardo, PR, 00738
Phone (787) 863-4840
Medicare paid, 2023
$11K
150 services
Medicare patients, 2023
21
Average age 76
Drug cost, 2024
$1.1M
23,475 prescriptions
Company payments, 2025
$90.4
From 1 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Ramon A Pastrana Maldonado was code 99213 (office e&m - established), 75 times for 12 patients. In total Ramon A Pastrana Maldonado billed 150 services in 8 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 75 | 12 | $48.53 | $3,639 |
By year: 2022 $6,539 for 100 services; 2023 $11K for 150 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramon A Pastrana Maldonado prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,283 prescriptions and refills. In total Ramon A Pastrana Maldonado wrote 23,475 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,283 | 1,721 | 221 | $9,655 |
| Losartan Potassium Generic | 879 | 1,196 | 144 | $7,351 |
| Gabapentin Generic | 842 | 1,090 | 138 | $11K |
| Simvastatin Generic | 770 | 1,059 | 120 | $4,708 |
| Famotidine Generic | 763 | 950 | 137 | $6,619 |
| Pentoxifylline Generic | 761 | 1,023 | 132 | $33K |
| Doxazosin Mesylate Generic | 738 | 988 | 115 | $8,989 |
| Omeprazole Generic | 727 | 922 | 138 | $6,155 |
| Metformin Hcl Generic | 626 | 843 | 108 | $3,581 |
| Synthroid Levothyroxine Sodium | 576 | 766 | 100 | $37K |
| Levothyroxine Sodium Generic | 505 | 673 | 89 | $4,934 |
| Meclizine Hcl Generic | 479 | 503 | 95 | $4,481 |
| Candesartan Cilexetil Generic | 460 | 614 | 70 | $29K |
| Glipizide Generic | 458 | 613 | 81 | $8,885 |
| Alendronate Sodium Generic | 392 | 497 | 61 | $2,530 |
Brand drugs: 3,098 claims; generic drugs: 20,058 claims; opioid claims: 77.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramon A Pastrana Maldonado $90.4 ($90.4 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $90.4.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $90.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.